相关实验视频

Updated: Jun 17, 2025

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
09:43

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses

Published on: March 8, 2024

1.6K

在细胞因子风暴综合征中IL-6阻塞

David Barrett1

  • 1Department of Pediatrics, University of Pennsylvania, Philadelphia, PA, USA. barrettd@chop.edu.

Advances in experimental medicine and biology
|August 8, 2024
PubMed

Insights

干联素-6 (IL-6) 阻断有效地治疗诸如HLH和MAS之类的细胞因子风暴综合征. 针对IL-6或其受体的已批准的疗法为这些炎症状况提供了安全有效的治疗选择.

科学领域:

  • 免疫学和炎症 免疫学和炎症
  • 在瘤学瘤学.
  • 传染性疾病 传染性疾病

背景情况:

  • 干乐素-6 (IL-6) 是一种关键的促炎细胞因子,涉及各种超炎症状况.
  • 在细胞因子风暴综合征 (CSS) 中观察到升高的IL-6水平,包括血细胞性淋巴细胞瘤 (HLH) 和巨细胞激活综合征 (MAS).
  • IL-6也与在CAR T细胞或双特异性T细胞诱导疗法和严重的SARS-CoV-2感染后的细胞因子释放综合征 (CRS) 相关.

研究的目的:

  • 审查针对IL-6途径的临床挑战,因为其复杂的受体相互作用.
  • 突出现有的IL-6阻断疗法的有效性和安全性,以管理CSS.
  • 讨论正在进行的对新型IL-6阻断策略的调查.

主要方法:

  • 对IL-6介导炎症状况的临床数据和治疗策略的审查.
  • 针对IL-6受体 (例如,托西利祖马布) 和IL-6本身 (例如,西尔图西马布) 的批准药物的分析.
  • 探索目前对先进IL-6阻断方法的研究.

主要成果:

  • 阻断IL-6在安全有效治疗各种细胞因子风暴综合征方面取得了显著的成功.
  • 针对IL-6或其受体综合体的已批准的治疗方法为CSS患者提供了可行的临床选择.
  • IL-6信号的复杂性为治疗开发带来了持续的挑战和机会.

结论:

  • 向IL-6是一种经过验证和有效的治疗策略,用于在HLH,MAS和CRS等疾病中管理严重的炎症反应.
  • 经批准的IL-6阻断剂提供了一种安全有效的手段来控制IL-6驱动的病理.
  • 对IL-6阻断机制和药物的进一步研究对于扩大治疗选择至关重要.
抽象的

No abstract available in PubMed .

关键词:
化学抗原受体的化学抗原受体细胞因子释放综合征 细胞因子释放综合征干扰素玛干扰素是一种干扰素.介乐金-6 介乐金-6 是一种互乐金-6受体的接收器在白血病中,白血病.这就是SARS-CoV-2病毒.这就是Siltuximab.托西利兹马布的使用方法gp13030 的使用情况.

更多相关视频

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety06:37

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on: September 15, 2023

560
In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function09:26

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

Published on: October 15, 2013

14.1K

相关概念视频

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.7K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
966
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
124
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.9K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
149
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K